Diagnostic
and monitoring device is one of the biggest product segments of global home
healthcare market with highest share. Home diagnostics is gaining recognition
as gadgets drives down the cost and provides a reliable degree of accuracy.
With increasing health awareness among people, increase in number of young and
geriatric people diagnosed with chronic diseases such as diabetes, cardiac
disorders and respiratory diseases,the demand for home diagnostics is expected
to grow even more in the next few years.
People
buy their at-home diagnostic tests and health-monitoring devices at pharmacies
or online. At home diagnostic products include blood pressure monitors; blood c
holesterollevel monitors; heart-rate monitors; blood glucose monitors, A 1 C
test kits, and monitoring supplies (including lancets and test strips); home
pregnancy and ovulation tests; and kits that require a blood or other tissue
sample to be sent out for testing, such as test kits for blood cholesterol
levels, HIV, hepatitis C, and DNA tests that can be used to prove paternity.
The latest to be added in this category is at-home cancer testing device for
screening lung, breast and prostate cancer. Some of the key industry
participants in global home diagnostic market includes 3M Health Care, Bayer
AG, Abbott Laboratories, Phillips Healthcare, Cardinal Health, Inc., GE
Healthcare, Gentiva Health Services, Inc., Johnson & Johnson Services,
Inc., F. Hoffmann-La
Roche Ltd., Medtronic, Inc., Omron Healthcare,
Inc. and Invacare Corporation among others.
No comments:
Post a Comment